KERATOCONUS IN NORTH INDIA: A DEMOGRAPHIC AND CLINICAL PROFILE STUDY

Main Article Content

Dr Kavya Bansal
Dr Rupali Kashyap
Dr Tanvi Gupta
Dr Tanisha Mittal

Keywords

.

Abstract

Purpose: To evaluate the demographic profile and clinical characteristics of newly diagnosed patients with keratoconus (KC) in North India and to analyze the relationship between age, sex, and disease severity.

Methods: A cross-sectional observational study was conducted at a tertiary eye care hospital between August 2020 and July 2022. Two hundred sixty-eight consecutive patients with clinically confirmed KC were included. Each underwent comprehensive evaluation, including visual acuity testing, slit-lamp biomicroscopy, and corneal imaging with the Sirius (CSO, Florence, Italy) systems [8]. Data regarding age, sex, and maximum keratometry (K max) were collected. KC severity was graded using K max. Statistical analyses were performed using SPSS v20, with p < 0.05 considered significant.

Results: The mean self-reported age at first presentation was 19.3 ± 6.1 years, and the mean age at diagnosis was 20.4 ± 6.0 years (range 4–43). Of the total patients, 62% (n = 166) were male and 38% (n = 102) were female. The mean K max was 59.4 ± 13.2 D. Most patients were diagnosed between 14 and 23 years, presenting with moderate-to-severe disease (K max = 51–61 D). Pediatric KC (≤ 18 years) accounted for 39% (n = 104), while adult KC (> 18 years) comprised 61% (n = 164). Pediatric cases showed significantly higher mean K max (62.1 ± 15.0 D) than adults (57.2 ± 11.4 D, p < 0.01). A weak negative correlation between age and K max (r = –0.21, p = 0.04) indicated a mild decline in severity with increasing age [9].



Conclusion: KC in North India presents predominantly in late adolescence and early adulthood with a male predominance [2]. Pediatric KC tends to be more severe. Regional screening and awareness programs are essential for early detection and intervention

Abstract 0 | PDF Downloads 0

References

Rabinowitz YS. Surv Ophthalmol. 1998;42(4):297–319.
2. Godefrooij DA et al. Am J Ophthalmol. 2017;175:169–181.
3. Meek KM, Knupp C. Prog Retin Eye Res. 2015;49:1–16.
4. Krachmer JH et al. Surv Ophthalmol. 1984;28(4):293–322.
5. McMonnies CW. Clin Exp Optom. 2013;96(1):2–15.
6. Pearson AR et al. Eye (Lond). 2000;14:625–628.
7. Weed KH et al. Eye. 2008;22(9):1158–1162.
8. Shah S et al. J Cataract Refract Surg. 2003;29(4):594–602.
9. Sharma N et al. Indian J Ophthalmol. 2020;68(5):743–748.
10. Agrawal VB. Eye Contact Lens. 2011;37(1):20–25.
11. Chen M et al. J Cataract Refract Surg. 2016;42(10):1416–1423.
12. Al-Saadi A et al. Middle East Afr J Ophthalmol. 2017;24(4):190–195.
13. Shneor E et al. Optom Vis Sci. 2014;91(7):958–964.
14. Al-Aqeel A et al. Saudi J Ophthalmol. 2018;32(2):122–126.
15. Hashemi H et al. J Curr Ophthalmol. 2017;29(1):1–9.
16. Georgiou T et al. Clin Exp Optom. 2004;87(5):356–360.
17. Shanti Y et al. Clin Ophthalmol. 2020;14:1395–1402.
18. Spoerl E et al. Invest Ophthalmol Vis Sci. 2011;52(14):9017–9022.
19. McKay TB et al. Exp Eye Res. 2020;190:107886.
20. Léoni-Mesplié S et al. Am J Ophthalmol. 2012;154(3):520–526.
21. Mukhtar S et al. Br J Ophthalmol. 2018;102(12):1716–1721.
22. Randleman JB et al. Ophthalmology. 2003;110(2):267–275.